$ABT
Abbott Laboratories
XNYS•Health Care•Pharmaceutical Preparations
$104.89
▲+0.20%+$0.210
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAbbott Laboratories
XNYS•Health Care•Pharmaceutical Preparations
Why is ABT up today? It is at $104.89 (+0.20%), and our scanner flagged it 65 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ABT spikes, and full due diligence on ABT — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ABT 65 times in the last 30 days. Create a free account to track $ABT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ABT from our scanner (live price and day move above). A recent catalyst in the news: “Forget High-Yield Traps: AbbVie Is the Dividend King to Buy and Hold Through Any Rate Cycle.”
Likely catalystAbbott reaches agreements to resolveReported awarded the plaintiff in the Gill case $495 million in damages. Abbott appealed the verdict to the Missouri Court of AppealsReported in December 2024, but the appeal was denied. Rather than continuing to appeal or paying approximately $600 million, representing the Gill judgmentReported claims asserted on behalf of approximately 2,000 additional infants for an aggregate amount of approximately $670, from an SEC filing. Read it →Latest filing4Ownership documentOct 2, 2026 · 14 days agoA share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Conroy Kevin T Director | Sold (automatic/other) | -53K | sold 39% | 81K | $5.5M at $103.99 | Sep 23, 26 |
Mccoy John A. Jr. Officer | Sold (automatic/other) | -27 | sold 0.1% | 25K | $3K at $109.54 | Sep 2, 26 |
Boudreau Philip P Officer | Sold (automatic/other) | -388 | sold 0.5% | 71K | $43K at $110.36 | Sep 1, 26 |
Mccoy John A. Jr. Officer | Sold (automatic/other) | -52 | sold 0.2% | 25K | $6K at $110.36 | Sep 1, 26 |
Ford Robert B Officer | Sold (automatic/other) | -399K 0.02% of company | sold 57% | 306K | $46.1M at $115.57 | Aug 25, 26 |
Ford Robert B Officer | Other | 399K 0.02% of company | added 100% | 705K | $17.7M at $44.40 | Aug 25, 26 |
Morrone Louis H. Officer | Sold (automatic/other) | -12 | n/a | n/a | $1K at $107.99 | Aug 12, 26 |
Morrone Louis H. Officer | Sold (automatic/other) | -6K | sold 7.6% | 71K | $643K at $109.83 | Aug 11, 26 |
Morrone Louis H. Officer | Sold (automatic/other) | -269 | sold 0.4% | 77K | $25K at $92.71 | Jun 30, 26 |
Cushman Elizabeth C. Officer | Sold (automatic/other) | -560 | sold 1.5% | 38K | $53K at $94.12 | Jun 27, 26 |
Stratton John G Director | Bought (open market) | +2K | added 9.4% | 23K | $174K at $86.82 | May 7, 26 |
Moreland Mary K Officer | Acquired (grant/award) | +5K | added 45% | 17K | $502K at $94.41 | Apr 28, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Curated groups ABT belongs to. Tap one to see every member with today's move and why the group is moving.
Here is the latest on ABT from our scanner (live price and day move above). A recent catalyst in the news: “Forget High-Yield Traps: AbbVie Is the Dividend King to Buy and Hold Through Any Rate Cycle.”
ABT last traded at $104.89, up 0.20% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Abbott Laboratories (ABT) is next expected to report earnings on Wednesday, October 21, 2026 (before open), about 4 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Yes. ABT currently has a dividend yield of about 2.40% ($2.52 per share per year). Dividend figures can change; this is not investment advice.
The ABT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ABT 65 times in the last 30 days.
ABT (Abbott Laboratories) trades on XNYS, with a market cap of about $182.70B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ABT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ABT discussion
Sign in to ask a question or join the discussion.